Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:948-954
Published online before print August 9, 2004, doi: 10.1161/01.CIR.0000139331.85766.AF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/8/948    most recent
01.CIR.0000139331.85766.AFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dessy, C.
Right arrow Articles by Balligand, J.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dessy, C.
Right arrow Articles by Balligand, J.L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NADOLOL
*NITRIC OXIDE
Related Collections
Right arrow Coronary circulation
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Circulation. 2004;110:948-954.)
© 2004 American Heart Association, Inc.


Original Articles

Endothelial ß3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization

C. Dessy, PhD; S. Moniotte, MD, PhD; P. Ghisdal, PhD; X. Havaux, MS; P. Noirhomme, MD; J.L. Balligand, MD, PhD

From the Unit of Pharmacology and Therapeutics (C.D., S.M., P.G., J.L.B.) and Divisions of Cardiology (X.H.) and Cardiovascular Surgery (P.N.), Saint-Luc University Clinic and Université Catholique de Louvain, Brussels, Belgium.

Correspondence to Dr J.L. Balligand, Unit of Pharmacology and Therapeutics, Université Catholique de Louvain, FATH5349, avenue E. Mounier 53, B-1200, Brussels, Belgium. E-mail Balligand{at}mint.ucl.ac.be

Received June 16, 2003; de novo received December 26, 2003; revision received May 6, 2004; accepted May 10, 2004.

Background— Coronary vessel tone is modulated in part by ß-adrenergic relaxation. However, the implication of specific ß-adrenoceptor subtypes and their downstream vasorelaxing mechanism(s) in human coronary resistance arteries is poorly defined. ß3-Adrenoceptors were recently shown to vasodilate animal vessels and are expressed in human hearts.

Methods and Results— We examined the expression and functional role of ß3-adrenoceptors in human coronary microarteries and their coupling to vasodilating nitric oxide (NO) and/or hyperpolarization mechanisms. The expression of ß3-adrenoceptor mRNA and protein was demonstrated in extracts of human coronary microarteries. Immunohistochemical analysis revealed their exclusive localization in the endothelium, with no staining of vascular smooth muscle. In contractility experiments in which videomicroscopy was used, the nonspecific ß-agonist isoproterenol and the ß3-preferential agonist BRL37344 evoked an {approx}50% relaxation of endothelin-1-preconstricted human coronary microarteries. Relaxations were blocked by the ß123-adrenoceptor antagonist bupranolol but were insensitive to the ß12-adrenoceptor antagonist nadolol, confirming a ß3-adrenoceptor-mediated pathway. Relaxation in response to BRL37344 was absent in human coronary microarteries devoid of functional endothelium. When human coronary microarteries were precontracted with KCl (thereby preventing vessel hyperpolarization), the relaxation to BRL37344 was reduced to 15.5% and totally abrogated by the NO synthase inhibitor L-{omega}-nitroarginine, confirming the participation of a NO synthase-mediated relaxation. The NO synthase-independent relaxation was completely inhibited by the Ca2+-activated K+ channel inhibitors apamin and charybdotoxin, consistent with an additional endothelium-derived hyperpolarizing factor-like response. Accordingly, membrane potential recordings demonstrated vessel hyperpolarization in response to ß3-adrenoceptor stimulation.

Conclusions— ß3-adrenoceptors are expressed in the endothelium of human coronary resistance arteries and mediate adrenergic vasodilatation through both NO and vessel hyperpolarization.


Key Words: receptors, adrenergic, beta • endothelium-derived factors • nitric oxide • vasodilation




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. F. Figueroa, I. Poblete, R. Fernandez, C. Pedemonte, V. Cortes, and J. P. Huidobro-Toro
NO production and eNOS phosphorylation induced by epinephrine through the activation of {beta}-adrenoceptors
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H134 - H143.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Rozec, M. Erfanian, K. Laurent, J.-N. Trochu, and C. Gauthier
Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1532 - 1538.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-L. Balligand
beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?".
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1539 - 1542.
[Full Text] [PDF]


Home page
HeartHome page
E. Barbato
Role of adrenergic receptors in human coronary vasomotion
Heart, April 1, 2009; 95(7): 603 - 608.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Frerart, P. Sonveaux, G. Rath, A. Smoos, A. Meqor, N. Charlier, B. F. Jordan, J. Saliez, A. Noel, C. Dessy, et al.
The Acidic Tumor Microenvironment Promotes the Reconversion of Nitrite into Nitric Oxide: Towards a New and Safe Radiosensitizing Strategy
Clin. Cancer Res., May 1, 2008; 14(9): 2768 - 2774.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Saliez, C. Bouzin, G. Rath, P. Ghisdal, F. Desjardins, R. Rezzani, L.F. Rodella, J. Vriens, B. Nilius, O. Feron, et al.
Role of Caveolar Compartmentation in Endothelium-Derived Hyperpolarizing Factor-Mediated Relaxation: Ca2+ Signals and Gap Junction Function Are Regulated by Caveolin in Endothelial Cells
Circulation, February 26, 2008; 117(8): 1065 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kou and T. Michel
Epinephrine Regulation of the Endothelial Nitric-oxide Synthase: ROLES OF RAC1 AND beta3-ADRENERGIC RECEPTORS IN ENDOTHELIAL NO SIGNALING
J. Biol. Chem., November 9, 2007; 282(45): 32719 - 32729.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Rouget, O. Barthez, F. Goirand, M.J. Leroy, M. Breuiller-Fouche, Z. Rakotoniaina, P. Guerard, E.J. Morcillo, C. Advenier, P. Sagot, et al.
Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia
Biol Reprod, January 1, 2006; 74(1): 209 - 216.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Dessy, J. Saliez, P. Ghisdal, G. Daneau, I. I. Lobysheva, F. Frerart, C. Belge, K. Jnaoui, P. Noirhomme, O. Feron, et al.
Endothelial {beta}3-Adrenoreceptors Mediate Nitric Oxide-Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation {beta}-Blocker Nebivolol
Circulation, August 23, 2005; 112(8): 1198 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Rozec, S. Serpillon, G. Toumaniantz, C. Seze, Y. Rautureau, O. Baron, J. Noireaud, and C. Gauthier
Characterization of Beta3-Adrenoceptors in Human Internal Mammary Artery and Putative Involvement in Coronary Artery Bypass Management
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 351 - 359.
[Abstract] [Full Text] [PDF]